ANTIBODIES THAT BIND INTERLEUKIN-2 AND USES THEREOF

The present disclosure relates, in general, to human antibodies against human interleukin 2 (IL-2) and methods of use of such antibodies for modulating IL-2 activity and use in the treatment of conditions such as cancer, autoimmune disease, or infection. La presente divulgación se refiere, en genera...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mark RUBINSTEIN, Lauren SCHWIMMER, Hassan ISSAFRAS, Daniel H. BEDINGER, Ou LI, Marina ROELL, Toshihiko TAKEUCHI, Amer M. MIRZA, Kristin Camfield LIND, Kirk W. JOHNSON, Hoa GIANG, Agnes Choppin HOLMES, Llewelyn LAO
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure relates, in general, to human antibodies against human interleukin 2 (IL-2) and methods of use of such antibodies for modulating IL-2 activity and use in the treatment of conditions such as cancer, autoimmune disease, or infection. La presente divulgación se refiere, en general, a anticuerpos humanos contra la interleucina 2 (IL-2) humana y a los métodos de uso de tales anticuerpos para modular la actividad de IL-2 y al uso en el tratamiento de afecciones tales como cáncer, enfermedad autoinmunitaria o infección.